WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 7'1101 Infant (under 12 months) mortality rate: 102
GDP / capita (US$): 10'8271 Child (under 5 years) mortality rate: 132

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 105  105  105  104  104  102  96  89 
Births
Surviving infants
Pop. less than 5 years 10  10  10  10  10  15  12 
Pop. less than 15 years 29  29  29  29  29  36  37  36 
Female 15-49 years 28  28  28  28  28  25  21  20 

Number of reported case

(Click for retrospective incidence data for Grenada)
Diphtheria
Japanese encephalitis
Measles 53 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Grenada)
Vaccine year result method % card seen                                                
BCG         
DTP1          90  92  91  92  100  99* 
DTP3          97  94  97  99  100  97  80  25 
HepB_BD         
HepB3          97  94  97  99  100 
Hib3          97  94  97  99  100  33 
JapEnc         
MCV          94  99*  97  99*  100  92  85 
MCV2          75  85  86  78  86 
PCV1         
PCV3         
Pol3          98  95  94  100  100  97  69  32 
Rota1         
Rota_last         
Rubella1          94  99*  97  99*  100 
TT2plus          10  11 
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Grenada)
DTP1 99  98  99  99  99  99  93  50 
DTP3 97  94  97  99  99  97  80  25 
HepB3 97  94  97  99  99 
Hib3 97  94  97  99  99  33 
MCV 94  95  95  98  99  92  85 
PCV3
Pol3 98  95  94  99  99  97  69  32 
Rota_last

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 86
From 80 to 89% 14
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
DT 4-5 years; Yes
DTwP 18 months; Yes
DTwPHibHep 6-8, 16-20, 24-28 weeks; Yes
HepB > 18 years (x3); Yes at risk groups
Influenza >= 6 months; >=7 months; Yes and risk groups
MMR 12, 18 months; Yes
OPV 6-8, 16-20, 24-28 weeks; 18 months; 4-5, >14 years; Yes
Td >7 years (x2); Yes
Varicella at risk groups

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  No  No 
What years does the MYP cover? number 2011- 2012  2008 -2012  2008-2012  2008-2012  2008 - 2012    NA 
Nº of districts with microplans that include activities to raise immunization coverage number

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR No  No  No         

System performance

Total number of districts in country number
Nº districts with DTP3 coverage >=80% number
% of districts with DTP3 coverage >=80% From 0 to 100% 100  86  100  100  100  86  100 
Nº districts with measles (MCV1) coverage >=95% number    
% of districts with MCV1 coverage >=95% From 0 to 100% 43  71  29  29  86     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 100  100  100  100  100  100  100 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.